Alteration of femoral bone morphology and density in COX-2-/- mice

Bone

Volumn 39, Issue 4, 2006, Pages 767-772

  Robertson, Galen ^a   Xie, Chao ^b   Chen, Di ^b   Awad, Hani ^b   Schwarz, Edward M ^b   O'Keefe, Regis J ^b   Guldberg, Robert E ^a   Zhang, Xinping ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone mineral density (BMD); COX 2; Postyield deflection (YPD)

Indexed keywords

CYCLOOXYGENASE 2;

ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE DESTRUCTION; BONE MASS; BONE MINERAL; BONE STRENGTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; ENZYME ACTIVATION; EPIPHYSIS; FEMALE; FEMUR; FRACTURE; IMAGE ANALYSIS; KNOCKOUT MOUSE; MALE; METAPHYSIS; MOUSE; NONHUMAN; PROTEIN FUNCTION; SPECIES COMPARISON; TRABECULAR BONE; WILD TYPE;

ANIMALS; BIOMECHANICS; BONE DENSITY; CYCLOOXYGENASE 2; FEMALE; FEMUR; MALE; MICE; MICE, KNOCKOUT; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748208646     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.04.006     Document Type: Article

References (43)

1. Alam I., Warden S.J., Robling A.G., and Turner C.H. Mechanotransduction in bone does not require a functional cyclooxygenase-2 (COX-2) gene. J Bone Miner Res 20 (2005) 438-446
2. Bauer D.C., Orwoll E.S., Fox K.M., Vogt T.M., Lane N.E., Hochberg M.C., et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11 (1996) 29-35
3. Brodt M.D., Ellis C.B., and Silva M.J. Growing C57Bl/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J Bone Miner Res 14 (1999) 2159-2166
4. Chen Q., Rho J.Y., Fan Z., Laulederkind S.J., and Raghow R. Congenital lack of COX-2 affects mechanical and geometric properties of bone in mice. Calcif Tissue Int 73 (2003) 387-392
5. Chikazu D., Li X., Kawaguchi H., Sakuma Y., Voznesensky O.S., Adams D.J., et al. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17 (2002) 1430-1440
6. Duncan R.L., and Turner C.H. Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int 57 (1995) 344-358
7. Forwood M.R. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res 11 (1996) 1688-1693
8. Goodman S., Ma T., Trindade M., Ikenoue T., Matsuura I., Wong N., et al. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 20 (2002) 1164-1169
9. Herschman H.R. Prostaglandin synthase 2. Biochem Biophys Acta 1229 (1996) 125-140
10. Hildebrand T., Laib A., Muller R., Dequeker J., and Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14 (1999) 1167-1174
11. Hildebrand T., and Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1 (1997) 15-23
12. Jee W.S., Ke H.Z., and Li X.J. Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats. Bone Miner 15 (1991) 33-55
13. Jiang J.X., and Cheng B. Mechanical stimulation of gap junctions in bone osteocytes is mediated by prostaglandin E2. Cell Commun Adhes 8 (2001) 283-288
14. Judex S., Garman R., Squire M., Busa B., Donahue L.R., and Rubin C. Genetically linked site-specificity of disuse osteoporosis. J Bone Miner Res 19 (2004) 607-613
15. Judex S., Garman R., Squire M., Donahue L.R., and Rubin C. Genetically based influences on the site-specific regulation of trabecular and cortical bone morphology. J Bone Miner Res 19 (2004) 600-606
16. Kawaguchi H., Pilbeam C.C., Vargas S.J., Morse E.E., Lorenzo J.A., and Raisz L.G. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 96 (1995) 539-548
17. Kawaguchi H., Raisz L.G., Voznesensky O.S., Alander C.B., Hakeda Y., and Pilbeam C.C. Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae. Endocrinology 135 (1994) 1157-1164
18. Kawata A., and Mikuni-Takagaki Y. Mechanotransduction in stretched osteocytes-temporal expression of immediate early and other genes. Biochem Biophys Res Commun 246 (1998) 404-408
19. Klein R.F., Mitchell S.R., Phillips T.J., Belknap J.K., and Orwoll E.S. Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res 13 (1998) 1648-1656
20. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., and Herschman H.R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266 (1991) 12866-12872
21. Lane N.E., Bauer D.C., Nevitt M.C., Pressman A.R., and Cummings S.R. Aspirin and nonsteroidal antiinflammatory drug use in elderly women: effects on a marker of bone resorption. The Study of Osteoporotic Fractures Research Group. J Rheumatol 24 (1997) 1132-1136
22. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83 (1995) 483-492
23. Mikuni-Takagaki Y. Mechanical responses and signal transduction pathways in stretched osteocytes. J Bone Miner Metab 17 (1999) 57-60
24. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83 (1995) 473-482
25. Morton D.J., Barrett-Connor E.L., and Schneider D.L. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study. J Bone Miner Res 13 (1998) 1924-1931
26. O'Banion M.K., Sadowski H.B., Winn V., and Young D.A. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266 (1991) 23261-23267
27. Okada Y., Lorenzo J.A., Freeman A.M., Tomita M., Morham S.G., Raisz L.G., et al. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 105 (2000) 823-832
28. Orwoll E.S., Belknap J.K., and Klein R.F. Sex specificity in the genetic determinants of peak bone mass. J Bone Miner Res 16 (2001) 1962-1971
29. Pilbeam C., Rao Y., Voznesensky O., Kawaguchi H., Alander C., Raisz L., et al. Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells. Endocrinology 138 (1997) 4672-4682
30. Raisz L.G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthr Cartil 7 (1999) 419-421
31. Raisz L.G., Alander C.B., Fall P.M., and Simmons H.A. Effects of prostaglandin F2 alpha on bone formation and resorption in cultured neonatal mouse calvariae: role of prostaglandin E2 production. Endocrinology 126 (1990) 1076-1079
32. Richards J.B., Joseph L., and Goltzman D. The effects of cyclooxygenase-2 inhibitors on bone mineral density: results from the CaMos study. J Bone Miner Res 20 (2005) S20
33. Simon A.M., Manigrasso M.B., and O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17 (2002) 963-976
34. Sirois J., Simmons D.L., and Richards J.S. Hormona regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat prevulatory follicles. Induction in vivo and in vitro. J Biol Chem 267 (1992) 11586-11592
35. Somerville J.M., Aspden R.M., Armour K.E., Armour K.J., DM, and R. Growth of C57BL/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int 74 (2004) 469-475
36. Tetradis S., Pilbeam C.C., Liu Y., and Kream B.E. Parathyroid hormone induces prostaglandin G/H synthase-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in the murine osteoblastic cell line MC3T3-E1. Endocrinology 137 (1996) 5435-5440
37. Wadhwa S., Choudhary S., Voznesensky M., Epstein M., Raisz L., and Pilbeam C. Fluid flow induces COX-2 expression in MC3T3-E1 osteoblasts via a PKA signaling pathway. Biochem Biophys Res Commun 297 (2002) 46-51
38. Wadhwa S., Godwin S.L., Peterson D.R., Epstein M.A., Raisz L.G., and Pilbeam C.C. Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway. J Bone Miner Res 17 (2002) 266-274
39. Wadleigh D.J., and Herschman H.R. Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. Biochem Biophys Res Commun 264 (1999) 865-870
40. Weinreb M., Machwate M., Shir N., Abramovitz M., Rodan G.A., and Harada S. Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue. Bone 28 (2001) 275-281
41. Xu M., Choudhary S., Goltzman D., Ledgard F., Adams D., Gronowicz G., et al. Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?. Endocrinology 146 (2005) 1843-1853
42. Zhang X., Morham S.G., Langenbach R., Young D.A., Xing L., Boyce B., et al. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 16 (2001) 660-670
43. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., and O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109 (2002) 1405-1415